[image: Picture1.png]
*COVID-19 Serological Assay Design: Lessons Learned*
*ABRF Antibody Interest Group Presentation Monday, July 27, 2020 11:00
a.m.โ12:00 p.m. ET *
Join Zoom session
<https://us02web.zoom.us/j/85207659502?pwd=c1FzRnJqYVQyUkdjSUNzeTRQQ0NmQT09>
Testing COVID-19 patients and asymptomatic people for active infection
using RT-PCR and past infection with a serological test are central to
understanding and managing the disease in a population. Core Scientists in
the ABRF Antibody Interest Group have been developing ELISAs to help their
institutions study SARS-CoV-2 seroconversion and will share the lessons
they have learned along the way.
Join us for this timely and informative presentation.
Moderator:
*David Blum, Ph.D.*
Director, Bioexpression and Fermentation Facility
Director, Master of Biomanufacturing and Bioprocessing
University of Georgia
Speakers:
*Scott Brown, Ph.D.*
Director, Immunologic Reagent Facility
Department of Immunology
St. Jude Childrenโs Research Hospital
*Frances Weis-Garcia, Ph.D.*
Head, Bi-Institutional Antibody and Bioresource Core Facility
Memorial Sloan Kettering Cancer Center
The Rockefeller University
ABRF has setup a way to register for the webinar so please click the link
below if you want to view the upcoming webinar
https://us02web.zoom.us/webinar/register/WN_Eo2QxmkdTWygqyaMHeNyxw
Rest of post
On Thu, Jul 9, 2020 at 10:31 AM David Blum <email obscured>> wrote:
> [image: Picture1.png]
>
>
>
> *COVID-19 Serological Assay Design: Lessons Learned*
>
>
>
>
>
> *ABRF Antibody Interest Group Presentation Monday, July 27, 2020 11:00
> a.m.โ12:00 p.m. ET *
>
> Join Zoom session
> <https://us02web.zoom.us/j/85207659502?pwd=c1FzRnJqYVQyUkdjSUNzeTRQQ0NmQT09>
>
>
>
> Testing COVID-19 patients and asymptomatic people for active infection
> using RT-PCR and past infection with a serological test are central to
> understanding and managing the disease in a population. Core Scientists
> in the ABRF Antibody Interest Group have been developing ELISAs to help
> their institutions study SARS-CoV-2 seroconversion and will share the
> lessons they have learned along the way.
>
>
>
> Join us for this timely and informative presentation.
>
>
>
> Moderator:
>
>
>
> *David Blum, Ph.D.*
>
> Director, Bioexpression and Fermentation Facility
>
> Director, Master of Biomanufacturing and Bioprocessing
>
> University of Georgia
>
>
>
> Speakers:
>
>
>
> *Scott Brown, Ph.D.*
>
> Director, Immunologic Reagent Facility
>
> Department of Immunology
>
> St. Jude Childrenโs Research Hospital
>
>
>
> *Frances Weis-Garcia, Ph.D.*
>
> Head, Bi-Institutional Antibody and Bioresource Core Facility
>
> Memorial Sloan Kettering Cancer Center
>
> The Rockefeller University
>
>
>